Explore every episode of the podcast Science at the Fifty-Third Degree

Science is all about getting a closer look, but instead of diving into a molecule or an organ, this episode zooms in on the person behind the science. In this episode of Science at the Fifty-Third Degree, host Dr. Nayiar Shahid goes behind the lab bench to explore the journey from student to success with Dr. Martin Munz. Spanning two continents and numerous postings, Dr. Munz shares how he has built a vibrant scientific community around his research on neural circuits.

From early work with tadpoles to whole-brain studies in mice, Dr. Munz discusses how key mentorships, early career funding, and a willingness to take high-impact risks have shaped his career. Now establishing his own lab at the University of Alberta with local support from the Stollery Children's Hospital Foundation through the Women's and Children's Health Research Institute (WCHRI), he is pushing the boundaries of neuroscience.

This episode covers:

● The story behind his 2014 Science paper investigating how neuronal activity impacts circuit development in Xenopus laevis tadpoles.

● His decision to move to Switzerland for a postdoc in Dr. Boton-Roska’s lab, expanding from retina research into embryonic neocortex development.

● The critical role of early career funding, specifically the Simons Foundation Bridge to Independence Fellowship.

● Transitioning from an experimental postdoc to a professor building a team and working with lab manager Araya at the University of Alberta.

● Navigating a high-risk, high-reward phase of launching ambitious research projects aimed at high-impact publications.

Forget the image of dusty shelves and quiet rooms. In this episode of Science at the Fifty-Third Degree, host Dr. Nayiar Shahid explores how the modern library has transformed into "mission control" for the information age. Joined by Janice Kung, a professional librarian at the University of Alberta, the discussion dives into the chaotic world of Artificial Intelligence (AI) and the crucial role librarians play as the "superheroes" of information literacy. 

As AI tools generate "hallucinations" and fake research papers, the challenge for scientists is no longer just finding data, but verifying if it is real. This episode introduces the CARE framework—a vital tool for evaluating AI-generated content—and discusses the ethics of AI in academic publishing. 

This episode covers:

● The evolution of libraries from analog sanctuaries to digital hubs. 

● How AI is changing the way researchers search for and filter data. 

● The danger of AI hallucinations and "noise" in scientific literature. 

● A breakdown of the CARE framework: Check the source, Analyze the info, Review for bias, and Evaluate accuracy. 

● Why AI cannot be a co-author and the importance of human accountability in research.

Most people see the fruit fly as a kitchen nuisance or an agricultural menace, but to cancer researchers, Drosophila is a giant in the field. In this episode of Science at the Fifty-Third Degree, host Dr. Nayiar Shahid talks with Dr. Sarah Hughes, a Medical Genetics professor at the University of Alberta.

Dr. Hughes explains why this tiny insect is a foundational tool for human oncology, sharing roughly 75% of human cancer genes. The conversation dives deep into the SNR1 gene (known as SMARCB1 in humans), a critical regulator of chromatin remodeling. When this regulation fails, neural stem cells become "confused," leading to aggressive pediatric brain tumors like Atypical Rhabdoid Tumors (ATRT).

This episode covers:

● Why fruit flies are powerful models for human organ systems.

● The role of SNR1/SMARCB1 in stopping proliferation and guiding cell differentiation.

● How "stem-cell-like" cells in the wrong place lead to tumor overgrowth.

● The future of RNA-based therapies to regulate protein production.

● The importance of lab culture and mentorship in driving scientific discovery.

What happens when the patient sitting across from you is the only person in the world with their specific condition? In traditional medicine, that's a problem. For Harry Wilton-Clark, it's the whole point.

In this episode of Science at the Fifty-Third Degree, host Dr. Nayiar Shahid talks with Harry Wilton-Clark, a researcher at the University of Alberta's Women and Children's Health Research Institute, about a quiet revolution happening at the edges of medicine — the rise of N-of-1 therapies. These are treatments designed not for thousands of patients, but for one.

Harry's work focuses on Duchenne muscular dystrophy, a rare and fatal disease that strikes children. Using a technique called exon skipping therapy, his lab designs what he calls "genetic band-aids" — molecules that bind to a specific mutation in a patient's DNA and hide it from the body, allowing it to function more normally. The therapy isn't built for a population. It's built for a child.

This episode covers:

What Duchenne muscular dystrophy is and why it's so difficult to treat

How exon skipping therapy works — and what a "genetic band-aid" actually does

Why traditional clinical trials fail rare disease patients — and what N-of-1 trials offer instead

How patient families and advocacy organizations are driving research breakthroughs

What it felt like when a mouse that wouldn't run — finally ran

Why a single patient's treatment could become a master key for thousands of others
Harry recently represented Canada at the Falling Walls Lab in Berlin — one of 100 researchers selected from around the world to present work breaking the boundaries of science's biggest problems. The wall he chose to break: the one standing between a child and a cure.